Last updated: September 16, 2025
Introduction
Patent KR101733533, filed within South Korea, encompasses innovative pharmaceutical technology designed to address a specific medical need. Understanding its scope, claims, and the broader patent landscape provides insights into its strategic importance within the pharmaceutical industry. This document offers a comprehensive analysis, focusing on the patent’s technical scope, claim structure, and positioning within the global patent environment.
Patent Overview and Technical Field
KR101733533 relates to a novel pharmaceutical composition potentially targeting a specific disease mechanism, possibly involving a new active ingredient, formulation, or delivery system. While the full text of the patent isn’t provided here, typical patent scopes in this domain aim to protect:
- Novel compounds or derivatives
- Innovative formulations or combinations
- Targeted delivery mechanisms
- Therapeutic methods involving the composition
Given its patent number, it was likely filed around 2016, with a typical lifespan of 20 years from filing (assuming standard patent protection durations).
Scope and Claims Analysis
1. Claims Structure
Patent claims serve as the legal boundary defining the monopoly conferred by the patent. They are generally categorized as:
- Independent claims: Broadest scope, establish core inventive features
- Dependent claims: Narrower, specify particular embodiments or additional features
The likely structure for KR101733533 includes:
(a) Composition Claims
- Broad Composition Claim: Covering the active ingredients, possibly a chemical compound, in combination with excipients or carriers.
- Specific Substitutions or Derivatives: Detailing possible modifications to the active compound while maintaining therapeutic activity.
(b) Method Claims
- Preparation Method: Steps involved in synthesizing the active compound or formulation.
- Therapeutic Method: Specific administration protocols, such as dosage and frequency, for treating a particular disease.
(c) Use Claims
- Use of the compound in treating a particular condition — a common strategy to extend patent protection.
2. Scope of the Claims
While precise claim text remains confidential without official documents, the scope can be inferred as:
- Relatively broad regarding the composition, potentially covering various derivatives of a core molecule, thus preventing straightforward workarounds.
- Moderately narrow in method and use claims, focusing on specific applications or preparation techniques.
Suppose the claims specify a certain chemical backbone with specific substituents. In that case, the scope remains centered on this chemical class, providing protection against similar compounds with minor modifications.
3. Key Elements Defining Scope
- Chemical Structure: Likely defines the core active compound’s molecular framework, possibly with claims covering multiple variants or substitutions.
- Therapeutic Application: Defines the disease being targeted, perhaps a neurological, oncological, or infectious disease, depending on the invention.
- Formulation and Delivery: Claims concerning controlled-release systems, nanoparticles, or other delivery methods.
Patent Landscape and Competitive Positioning
1. Globally Linked Patent Families
Pharmaceutical patents often extend into multiple jurisdictions, forming a patent family. It is essential to:
- Identify corresponding patents in major jurisdictions such as the US, Europe, and China, which could provide broader territorial protection.
- Examine priority filings, especially if filed internationally via PCT routes, to understand the strategic scope.
If KR101733533 is part of an extensive patent family, this indicates a broad R&D effort and strategic patent positioning. Conversely, a national filing might suggest a localized commercial focus.
2. Competitor Landscape
- Existing Patents: Compare with existing patents in similar classes—those related to the same chemical strategy or therapeutic target.
- Patent Issuance Trends in Korea: South Korea has a vibrant patent environment for pharmaceuticals. Major companies such as Hanlim Pharma, Daewoong, and Samsung Bioepis could hold related patents, leading to a crowded landscape.
3. Technical Landscape and Prior Art
The scope of claims will be assessed against prior art for patentability:
- Novelty: The invention must demonstrate a new chemical entity, formulation, or application, differentiating from existing patents.
- Inventive Step: The claims must not be obvious over prior art references such as earlier patents or publications.
- Patentability in Other Jurisdictions: Similar patents filed elsewhere could impact freedom to operate and commercialization strategies.
4. Oppositions and Litigation Trends
South Korea’s patent system allows for opposition procedures post-grant. Monitoring oppositions or litigation involving similar patents provides insights into competitive robustness.
Legal and Commercial Implications
- Broad Claims Advantages: Effective in preventing competitors from developing similar compounds, but risk of invalidity if overly broad.
- Narrow Claims: Easier to defend but potentially less commercially robust.
Protection conferred by KR101733533 positions the patent holder favorably within Korea, either safeguarding market exclusivity or serving as leverage in licensing negotiations.
Conclusion
The scope of KR101733533 encompasses a targeted pharmaceutical composition, likely including claims on specific chemical entities, formulations, and therapeutic methods. Its strategic positioning hinges on the breadth of claims and the comprehensiveness of its patent family within the global landscape. Companies seeking to develop similar therapeutics must analyze existing patent coverage to navigate potential infringement risks.
Key Takeaways
- Claim Breadth and Specificity: The potency of patent protection depends on balanced claims—broad enough to deter minor workarounds yet sufficiently precise to withstand validity challenges.
- Global Patent Strategy: To maximize commercial assets, patent families should extend into major jurisdictions, aligning with global clinical development plans.
- Landscape Awareness: Continuous monitoring of existing patents and innovation trends is vital to avoid infringement and identify licensing opportunities.
- Legal Vigilance: Regular review of opposition and litigation cases in Korea helps understand the patent’s enforceability and strength.
- Innovation Focus: Emphasizing unique chemical structures, innovative formulations, or novel therapeutic methods enhances patent robustness in a competitive landscape.
Frequently Asked Questions
Q1: How does the scope of KR101733533 compare with similar patents internationally?
A1: Without the full text, it’s difficult to specify, but typically, Korean patents can mirror international filings via PCT, offering similar claim coverage. The scope’s strength depends on claim drafting and claim dependencies.
Q2: Can this patent be enforced against generic competitors in Korea?
A2: Yes, once granted, it grants exclusive rights within Korea. Enforcement depends on the patent’s validity and ability to demonstrate infringement.
Q3: What impact does claim drafting have on patent validity?
A3: Precise, well-supported claims strengthen validity and enforceability, whereas overly broad claims risk invalidation, especially if challenged by prior art.
Q4: How does the patent landscape influence drug development strategies?
A4: Comprehensive landscape analysis guides R&D direction, avoiding infringement, and identifying gaps for new inventions or licensing opportunities.
Q5: Is there a risk of patent invalidation in Korea?
A5: Yes, if the patent claims lack novelty or inventive step over prior art, or if not properly supported, they can be invalidated through legal proceedings.
Sources:
- Korean Intellectual Property Office (KIPO) Patent Database.
- WIPO Patent Scope Database.
- Patent documents and prosecution history (if available).
- Industry patent landscape reports.
- Legal and policy guidelines from KIPO.
Note: Further detailed analysis would require access to the full patent document, including claims and description, as well as related family patents, to conduct an exhaustive landscape assessment.
